DK1654284T3 - Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning - Google Patents

Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning

Info

Publication number
DK1654284T3
DK1654284T3 DK04764046T DK04764046T DK1654284T3 DK 1654284 T3 DK1654284 T3 DK 1654284T3 DK 04764046 T DK04764046 T DK 04764046T DK 04764046 T DK04764046 T DK 04764046T DK 1654284 T3 DK1654284 T3 DK 1654284T3
Authority
DK
Denmark
Prior art keywords
a1at
preparing
alpha
detergents
antitrypsin solution
Prior art date
Application number
DK04764046T
Other languages
Danish (da)
English (en)
Inventor
Petra Schulz
Juergen Roemisch
Original Assignee
Octapharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Octapharma Ag filed Critical Octapharma Ag
Application granted granted Critical
Publication of DK1654284T3 publication Critical patent/DK1654284T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0082—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using chemical substances
    • A61L2/0088—Liquid substances
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0017—Filtration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L2/00—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor
    • A61L2/0005—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts
    • A61L2/0011—Methods or apparatus for disinfecting or sterilising materials or objects other than foodstuffs or contact lenses; Accessories therefor for pharmaceuticals, biologicals or living parts using physical methods
    • A61L2/0023—Heat
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/81—Protease inhibitors
    • C07K14/8107—Endopeptidase (E.C. 3.4.21-99) inhibitors
    • C07K14/811—Serine protease (E.C. 3.4.21) inhibitors
    • C07K14/8121—Serpins
    • C07K14/8125—Alpha-1-antitrypsin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicinal Preparation (AREA)
DK04764046T 2003-08-12 2004-08-12 Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning DK1654284T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US49409703P 2003-08-12 2003-08-12
PCT/EP2004/009043 WO2005014648A1 (en) 2003-08-12 2004-08-12 Process for preparing an alpha-1-antitrypsin solution

Publications (1)

Publication Number Publication Date
DK1654284T3 true DK1654284T3 (da) 2009-07-20

Family

ID=34135316

Family Applications (1)

Application Number Title Priority Date Filing Date
DK04764046T DK1654284T3 (da) 2003-08-12 2004-08-12 Fremgangsmåde til fremstilling af en alfa-1-antitrypsinoplösning

Country Status (22)

Country Link
US (1) US20060194300A1 (pt)
EP (1) EP1654284B1 (pt)
JP (1) JP4668904B2 (pt)
KR (1) KR20060070543A (pt)
CN (1) CN1867582B (pt)
AT (1) ATE428730T1 (pt)
AU (1) AU2004262578B2 (pt)
BR (1) BRPI0412835A (pt)
CA (1) CA2534900A1 (pt)
DE (1) DE602004020632D1 (pt)
DK (1) DK1654284T3 (pt)
ES (1) ES2324168T3 (pt)
IL (1) IL172868A0 (pt)
NO (1) NO20060109L (pt)
PL (1) PL1654284T3 (pt)
PT (1) PT1654284E (pt)
RS (1) RS20060077A (pt)
RU (1) RU2370500C2 (pt)
SI (1) SI1654284T1 (pt)
UA (1) UA86775C2 (pt)
WO (1) WO2005014648A1 (pt)
ZA (1) ZA200601206B (pt)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005027821A2 (en) * 2003-09-22 2005-03-31 Kamada Ltd. Large scale preparation of alpha-1 proteinase inhibitor and use thereof
ES2246694B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Nanoparticulas pegiladas.
ES2246695B1 (es) 2004-04-29 2007-05-01 Instituto Cientifico Y Tecnologico De Navarra, S.A. Composicion estimuladora de la respuesta inmunitaria que comprende nanoparticulas a base de un copolimero de metil vinil eter y anhidrido maleico.
CN100354301C (zh) * 2005-10-13 2007-12-12 南京工业大学 化学合成多肽的新型大规模分离制备技术
HUE030205T2 (en) 2007-11-02 2017-05-29 Grifols Therapeutics Inc A method, composition, and product for providing alpha-1-antitrypsin
CN102127165B (zh) * 2010-01-15 2013-09-04 上海莱士血液制品股份有限公司 一种从血浆组分四沉淀中制备高纯ApoA-I的生产工艺
CN102731642B (zh) * 2011-04-14 2014-01-29 上海莱士血液制品股份有限公司 从人血浆组分四沉淀制备高纯Apoa-I的生产工艺
US9353165B2 (en) 2012-07-25 2016-05-31 Grifols, S.A. Purification of cell culture derived alpha1 protease inhibitor
AU2013205138B2 (en) 2012-08-09 2015-06-25 Grifols, S.A. Caprylate Viral Deactivation
CN107709350A (zh) 2015-06-26 2018-02-16 辉凌公司 纯化和/或病毒灭活的方法
MX2018009331A (es) * 2016-02-03 2018-11-09 Plasma Tech Llc Metodos para extraer proteinas a partir de un material a base de sangre.
CN111991571B (zh) * 2020-08-12 2022-04-05 湖州师范学院 一种柱上低pH病毒灭活的方法

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS584728A (ja) * 1981-05-01 1983-01-11 メデイカル・リサ−チ・インステイチユ−ト・オブ・サンフランシスコ・コ−ポレ−シヨン α−１−抗トリプシンの精製
US4684723A (en) * 1985-09-11 1987-08-04 Miles Laboratories, Inc. Method of separating proteins from aqueous solutions
US4629567A (en) * 1986-03-07 1986-12-16 Smithkline-Rit Alpha-1-antiprotease purification
DE3877041T2 (de) * 1987-04-27 1993-04-22 Miles Inc Verfahren zur herstellung von hochgereinigtem alpha-1-proteinase-inhibitor.
KR920005689B1 (ko) * 1989-12-21 1992-07-13 국제약품공업주식회사 혈청으로부터 알파-1-안티트립신의 분리 정제 및 혈중 알파-1-안티트립신 양의 검정키트
DE4125625C2 (de) * 1991-08-02 1999-12-02 Octapharma Ag Glarus Verfahren zur Herstellung von virusinaktivierten Immunglobulinlösungen
SE9301582D0 (sv) * 1993-05-07 1993-05-07 Kabi Pharmacia Ab Purification of plasma proteins
DE4407837C1 (de) * 1994-03-09 1995-08-17 Octapharma Ag Verfahren zur Gewinnung von hochreinem, virusinaktiviertem alpha¶1¶-Antitrypsin mittels Anionenaustauscher-Chromatographie
US6284874B1 (en) * 1994-06-17 2001-09-04 Alpha Therapeutic Corporation Process for separating α1-proteinase inhibitor from cohn fraction IV1 and IV4 paste
JP4105249B2 (ja) * 1996-08-09 2008-06-25 財団法人化学及血清療法研究所 α２プラスミンインヒビターの製造方法
AT407114B (de) * 1997-06-10 2000-12-27 Immuno Ag Alpha 1-antitrypsin-präparation sowie verfahren zu deren herstellung

Also Published As

Publication number Publication date
WO2005014648A1 (en) 2005-02-17
RU2370500C2 (ru) 2009-10-20
BRPI0412835A (pt) 2006-09-26
CN1867582A (zh) 2006-11-22
AU2004262578A1 (en) 2005-02-17
JP4668904B2 (ja) 2011-04-13
US20060194300A1 (en) 2006-08-31
CA2534900A1 (en) 2005-02-17
KR20060070543A (ko) 2006-06-23
JP2007523883A (ja) 2007-08-23
ATE428730T1 (de) 2009-05-15
SI1654284T1 (sl) 2009-10-31
PL1654284T3 (pl) 2009-09-30
DE602004020632D1 (de) 2009-05-28
CN1867582B (zh) 2010-06-16
UA86775C2 (ru) 2009-05-25
NO20060109L (no) 2006-02-15
ES2324168T3 (es) 2009-07-31
IL172868A0 (en) 2006-06-11
EP1654284B1 (en) 2009-04-15
RU2006107533A (ru) 2006-07-27
PT1654284E (pt) 2009-07-06
ZA200601206B (en) 2007-05-30
AU2004262578B2 (en) 2010-05-06
RS20060077A (en) 2008-08-07
EP1654284A1 (en) 2006-05-10

Similar Documents

Publication Publication Date Title
NO20060109L (no) Fremgangsmate for fremstilling av alfa- 1antitrypsinlosning
DE60334678D1 (de) Antikörper enthaltende pharmazeutische lösungen
NZ593214A (en) Compounds and Processes for preparing serine protease inhibitors
EA200201012A1 (ru) Способы стерилизации биологических материалов
WO2004037784A3 (en) Pyrrolidones with anti-hiv activity
ATE231496T1 (de) Saccharinderivate als proteolytische enzyminhibitoren
EP1831239B8 (en) A process for the preparation of 17-hydroxy-6 beta, 7 beta, 15 beta, 16 beta -bismethylene-17 alpha-pregn-4-ene-3-one-21-carboxylic acid gamma-lactone and key-intermediates for this process
ES2139071T3 (es) Agente insecticida y acaricida derivado del triazol y proceso para la produccion del mismo.
DE60307268D1 (de) Pestizide pyridincarbonsäureamidderivate
DE60221508D1 (de) Aminosäurederivate als hiv-protease-inhibitoren
DK1718673T3 (da) Fremgangsmåde til rensning af albumin omfattende et nanofiltreringstrin, oplösning og sammensætning til terapeutisk anvendelse, som indeholder det
SE0300850D0 (sv) Chemical compounds
HK1053826B (zh) 丙稀羧酸胺肟衍生物，其製備方法，含有它的組合物
DK0828721T3 (da) 2-Aminobenzoxazinoner til behandling af virale infektioner
ATE272436T1 (de) Mikrofiltration unter verwendung von aktivkohle
EA200200502A1 (ru) Способ введения ингибитора фосфодиэстеразы 4
DK1664123T4 (da) Storskalafremstilling af alfa-1-proteinaseinhibitor og anvendelse deraf
SE0200843D0 (sv) Chemical compounds
GB2411401A (en) Process for production of alkanesulfonic acid
WO2004037853A3 (en) Quinolones with anti-hiv activity
DE502004005055D1 (de) Oxaliplatinlösungskonzentrate
SE9904289D0 (sv) Method and camposition for the treatment of adenovairal ocular infections
AU2003302275A1 (en) Bicyclic carbohydrate compounds useful in the treatment of infections caused by flaviviridae sp., such as hepatitis c and bovine viral diarrhea viruses
DK1214315T5 (da) 1,4-Dihydropyridin-5-carboxylsyreesterderivater og fremgangsmåde til fremstilling af samme
ATE491709T1 (de) Pyrrolidinohydrochinazoline